[{"NetIncomeLoss_1_Q1_USD":-23301000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q1_shares":401831.0,"OperatingLeaseLiability_0_Q1_USD":4889000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"GeneralAndAdministrativeExpense_1_Q1_USD":6365000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":49917990.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":80747000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":70000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q1_pure":0.7184,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":12000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q1_pure":0.0121,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":13869000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":59000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":14880000.0,"AssetsCurrent_0_Q1_USD":188351000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1_Q1_USD":0.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q1_USD":39000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":23985000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_1_Q1_USD":0.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":688000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1992000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-61000.0,"CommonStockSharesIssued_0_Q1_shares":50026667.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":646015000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":205791000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":3250000.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":2336000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":19131000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":5393000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":59000.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":942000.0,"ProceedsFromSaleOfAvailableForSaleSecurities_1_Q1_USD":8029000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":27655000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":49917990.0,"PrepaidExpenseCurrent_0_Q1_USD":13018000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":260000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"CommonStockValue_0_Q1_USD":50000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":56728000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q1_position":27.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded_1_Q1_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-2001000.0,"OtherReceivablesNetCurrent_0_Q1_USD":2244000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q1_USD":56728000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":63000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q1_USD":149031000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":688000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":59000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":228310000.0,"OtherPrepaidExpenseCurrent_0_Q1_USD":454000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q1_USD":39000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-23362000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":22519000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1444000.0,"Assets_0_Q1_USD":250228000.0,"ShareBasedCompensation_1_Q1_USD":4132000.0,"CommonStockSharesOutstanding_0_Q1_shares":50026667.0,"RestrictedCashNoncurrent_0_Q1_USD":408000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":71000.0,"ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_1_Q1_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-23301000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":70000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2744000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-23721000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_1_Q1_USD":0.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1_Q1_USD":8029000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":49917990.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":149063000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":1957000.0,"LiabilitiesCurrent_0_Q1_USD":16519000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-9164000.0,"AccountsPayableCurrent_0_Q1_USD":4765000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":22927000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q1_pure":0.7162,"ProceedsFromStockOptionsExercised_1_Q1_USD":688000.0,"IncreaseDecreaseInOtherReceivables_1_Q1_USD":1687000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q1_pure":0.0066,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":80747000.0,"PrepaidInsurance_0_Q1_USD":2007000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":778000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-415618000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-61000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":5918808.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":205779000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":3963000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"InterestReceivableCurrent_0_Q1_USD":346000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q1_USD":56748000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":504000.0,"OtherComprehensiveIncomeLossTax_1_Q1_USD":0.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1935000.0,"OperatingIncomeLoss_1_Q1_USD":-23561000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":149063000.0,"IncomeTaxesReceivable_0_Q1_USD":1507000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":250228000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2604000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q1_USD":1388000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q1_USD":0.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1639000.0,"OperatingExpenses_1_Q1_USD":25496000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.47,"ProfitLoss_1_Q1_USD":-23301000.0,"StockholdersEquity_0_Q1_USD":230459000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q1_USD":0.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-194000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":589000.0,"Ticker":"CARA","CIK":"1346830","name":"CARA THERAPEUTICS, INC.","OfficialName":"Cara Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"703167627.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]